IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Sarepta Therapeutics, Inc.
Symbol: SRPT
Price: Last trade $56.09
Trade Date: 9/23
Shares: 4 million
Underwriter(s) J.P. Morgan, Goldman Sachs, Credit Suisse
Rating=Subscription Needed
Company: Chesapeake Utilities Corporation
Symbol: CPK
Price: Last trade $63.75
Description: Re-offer $62.26
Trade Date: 9/22
Shares: 815,000
Underwriter(s) Wells Fargo Securities, RBC Capital Markets
Co Manager(s) Janney Montgomery Scott, Baird, J.J.B. Hilliard, W.L. Lyons, Ladenburg Thalmann, U.S. Capital Advisors, BB&T Capital Markets
Rating=Subscription Needed